Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-08-000037
Filing Date
2008-08-14
Accepted
2008-08-14 14:40:00
Documents
7
Period of Report
2008-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-063008.htm 10-Q 469022
2 AGREEMENT AND PLAN OF MERGER ex_2-3.htm EX-2.3 560473
3 CERTIFICATE OF AMENDMENT ex_3-11.htm EX-3.11 20591
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 16898
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 17291
6 CEO CERTIFICATION ex_32-1.htm EX-32.1 5969
7 CFO CERTIFICATION ex_32-2.htm EX-32.2 5757
  Complete submission text file 0000318306-08-000037.txt   1097621
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 081017911
SIC: 2834 Pharmaceutical Preparations